MSU Drug Discovery

Toggle Accessibility Tools

Welcome to MSU Drug discovery 

NEWS

  • MSU DD Seminar Series: Dr. John Beutler (NIH/NCI), Friday, October 23, at 9am 

  • "Hyperphosphorylated tau aggregation and cytotoxicity modulators screen identified prescription drugs linked to Alzheimer's disease and cognitive functions" Liu et al., Scientific Reports, October 2020

https://www.nature.com/articles/s41598-020-73680-2

https://doi.org/10.1021/acschembio.8b00849

  • "Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance" Williams, et al., Antimicrobial Agents and Chemotherapy Sept. 2019

https://aac.asm.org/content/63/10/e00547-19.long

 

 

MSU DD Graphic

Upcoming Events

Sparty head logo
Drug Discovery Seminar Series 

Services

ADDRC logo click

  • High throughput screening
  • Automated laboratory robotics
  • Hit selection

InVivo logo click

  • Efficacy testing in normal & disease models
  • Safety testing
  • Imaging
  • In vivo techical assistance
  • PK studies 

MCFpoint

  • Active pharmaceutical ingredient development
  • Screening & target validation
  • Series identification & Scale-up

Other Resources Available:

Molecular Interaction ANalysis

pharmacokinetics

Consultation